苯磺酸氨氯地平片与吲达帕胺片治疗原发性高血压高龄患者的疗效比较  

Comparision of Therapy on Treating Primary Hypertension Senile Patients between Amlodipine Besylate Tablets and Indapamide Tablets

作　　者：刘健[1] 匡红英[2] 

机构地区：[1]湖南环境生物职业技术学院,湖南衡阳421001 [2]南华大学附属第一医院,湖南衡阳421001

出　　处：《湖南师范大学学报（医学版）》2008年第3期26-28,共3页Journal of Hunan Normal University(Medical Sciences)

摘　　要：目的:观察苯磺酸氨氯地平片治疗原发性高血压高龄(>80岁)患者的临床疗效和安全性。方法:105例高龄高血压患者随机分为2组,Ⅰ组(n=53)给予苯磺酸氨氯地平5 mg/d;Ⅱ组(n=52)给予吲达帕胺2.5 mg/d,观察8周。结果:治疗后两组收缩压和舒张压均有明显降低,与治疗前比较有统计学意义(P<0.05),Ⅰ组的降压幅度略优于Ⅱ组,但两组间疗效差异无统计学意义(P>0.05),苯磺酸氨氯地平片的不良反应少于吲达帕胺片。结论:苯磺酸氨氯地平片治疗原发性高血压高龄患者安全有效,可作为原发性高血压高龄患者的降压一线用药。Objective Observing clinical therapy and security of treating primary hypertension hypertension senile(>80 years) patients on amlodipine besylate tablets.Methods 105 senile primary hypertension patients were divided randomly into two groups.The patients in groupⅠ(n=53) took amlodipine besylate tablet(5mg/d) by mouth;the patients in groupⅡ(n=52) took indapamide tablet(2.5mg/d) by mouth.They were observed in eight weeks.Results Both systolic blood pressure and diastolic blood pressure decreased obviously afte...

关 键 词：高龄人 高血压 苯磺酸氨氯地平片 吲达帕胺片 

分 类 号：R544.1[医药卫生—心血管疾病]